(1) have demonstrated that WRN contributes to general RNA pol II 4 -dependent transcription, although its mechanism remains unclear. Interestingly, these authors found that a 27-amino acid direct-repeat sequence strongly activated transcription in yeast two-hybrid experiments, independent of WRN 3Ј 3 5Ј DNA helicase activity (1) (Fig. 1A) suggesting that WRN interacts with cellular factors to modulate RNA pol II-dependent transcription. The WRN protein localizes to nucleoli and the nucleoplasm of transcriptionally active cells (1, 2). Moreover, Laine et al. (3) have shown that WRN stimulates topoisomerase I DNA-unwinding activity that could influence cellular transcription. The yeast WRN homologue, SGS1, also participates in DNA replication and RNA pol I-dependent transcription (4), and the WRN helicase enhances RNA pol I-dependent transcription of ribosomal RNA (5).
Several lines of investigation allude to a role for the WRN protein and RecQ DNA helicases in transcription. Balajee et al. (1) have demonstrated that WRN contributes to general RNA pol II 4 -dependent transcription, although its mechanism remains unclear. Interestingly, these authors found that a 27-amino acid direct-repeat sequence strongly activated transcription in yeast two-hybrid experiments, independent of WRN 3Ј 3 5Ј DNA helicase activity (1) (Fig. 1A) suggesting that WRN interacts with cellular factors to modulate RNA pol II-dependent transcription. The WRN protein localizes to nucleoli and the nucleoplasm of transcriptionally active cells (1, 2) . Moreover, Laine et al. (3) have shown that WRN stimulates topoisomerase I DNA-unwinding activity that could influence cellular transcription. The yeast WRN homologue, SGS1, also participates in DNA replication and RNA pol I-dependent transcription (4) , and the WRN helicase enhances RNA pol I-dependent transcription of ribosomal RNA (5) .
In the present study, we have investigated whether WRN contributes to HIV-1 LTR transactivation and retroviral replication. The HIV-1 LTR contains upstream enhancer elements (e.g. NF-B and SP1) that synergize with the transactivator protein, Tat, bound to TAR-RNA, to promote retroviral gene expression in HIV-1-infected tissues, macrophages/monocytes, and CD4 ϩ T-lymphocytes (6 -17) . The mechanism by which Tat/TAR-RNA complexes regulate transcription from the HIV-1 LTR involves the concerted recruitment of a plethora of cellular factors, including p300/CREB-binding protein (p300/CBP) (18 -25) , PCAF/hGCN5 (20 -22, 26 -30) , P-TEFb (30 -33) , SET7/SET9 methyltransferases (34) , SIRT1 (35) , the Brm component of the SWI/SNF chromatin-remodeling com-plex (36) , and the splicing factor, SKIP (37) . The Tat protein is acetylated on Lys 28 , Lys 50 , and Lys 51 by the transcriptional coactivators/acetyltransferases, p300/CBP and PCAF/hGCN5 (20 -22, 24, 27-30, 38) , which has been shown to modulate Tat interactions with P-TEFb and Brm, as well as the ability of Tat for binding TAR-RNA (20, 30, 35, 36, 39) . The formation of Tat/TAR-RNA/P-TEFb/PCAF complexes on the HIV-1 LTR stimulates Ser 2 -Ser 5 -phosphorylation of the RNA pol II carboxyl-terminal domain associated with increased transcriptional elongation (30, 37, 40) . Importantly, our results demonstrate that the WRN helicase interacts and cooperates with Tat to transactivate the HIV-1 LTR to promote retroviral replication through the stable recruitment of PCAF/P-TEFb to Tat/ TAR-RNA transcription complexes.
EXPERIMENTAL PROCEDURES
Plasmids and Transfection-pCV126 RSV-HIV-1 Tat (exon 1: amino acids 1-72, FLAG-tagged), pCV122 RSV-HIV-1 Tat K28A/K50A , pEV284 HIV-1 LTR-luciferase (contains pBRULTR nucleotides 345-531), and pGEX-GST-HIV-1 Tat (HA) and pGEX-GST-HIV-1 Tat K28A/K50A (HA) plasmids were described by Kiernan et al. (20) . pCV63 HIV-1 LTR⌬TAR-luciferase is deleted for the 3-nucleotide bulge within TAR-RNA; and the episomal pCV745 HIV-1 LTR-luciferase construct used in ChIP analyses contains an XhoI-BamHI fragment that spans the HIV-1 LTR. CMV-wild type-WRN and CMV-WRN K577M expression constructs have been described in Moser et al. (41) . All transfections were performed using Lipofectamine (Invitrogen) or Superfect (Qiagen) reagents.
Cell Culture and Concentration of Retrovirus Particles-SV40-immortalized human WRN Ϫ/Ϫ WS fibroblasts (41), 293A fibroblasts (Quantum Biotechnology), and HeLa cells (ATCC, CCL-2) were grown in Dulbecco's modified Eagle's medium (ATCC) supplemented with 10% fetal bovine serum (Atlanta Biologicals), 100 units/ml penicillin, and 100 g/ml streptomycin sulfate (Invitrogen) and cultured at 37°C and 5% CO 2 . HuT-78 cells (ATCC, TIB-161) were grown in RPMI 1640 medium (ATCC) supplemented with 20% fetal bovine serum, and 100 units/ml penicillin, 100 g/ml streptomycin sulfate, and 20 g/ml gentamycin sulfate (Sigma Corp.), and cultured at 37°C and 10% CO 2 . The HIV-1-infected H9 HIV-1IIIB lymphoid cell line (derived from HuT-78; ATCC, CRL-8543, Ref. 40) was cultured under identical conditions. To induce high level HIV-1 replication and the production of infectious viral particles, HIV-1-infected H9 HIV-1IIIB lymphocytes were stimulated with 50 units/ml recombinant human interleukin-2 (hIL-2; Invitrogen) and phytohemagglutinin (10 ng/ml, Sigma) for 72-96 h. Cells were pelleted by centrifugation at 1,500 ϫ g for 7 min at 4°C and the supernatants were filtered through a 0.45-m filter and layered upon a 70% sucrose, Tris-HCl, pH 7.4, cushion. HIV-1 particles were concentrated by ultracentrifugation at 44,000 ϫ g for 24 h at 4°C using a Beckman 70.1 Ti rotor and a model L8 -70 M ultracentrifuge.
Chromatin Immunoprecipitation-3 ϫ 10 6 HeLa cells or WRN Ϫ/Ϫ WS fibroblasts were co-transfected with an episomal HIV-1 LTR-luciferase (pCV745) plasmid and RSV-HIV-1 Tat using Superfect reagent (Qiagen). CMV-WRN K577M was cotransfected in certain experiments to inhibit the endogenous WRN helicase (41, 42) . Chromatin immunoprecipitations were performed by incubating precleared lysates with 40 l of protein G-agarose/sheared salmon sperm DNA (Upstate Biotechnology) and 5 l of rabbit polyclonal anti-HIV-1 Tat (Advanced Bioscience Laboratories), goat polyclonal anti-WRN (Santa Cruz Biotechnology), monoclonal anti-p300 (Upstate Biotechnology), goat polyclonal anti-PCAF (Santa Cruz Biotechnology), goat polyclonal anti-cyclin T1 (Santa Cruz Biotechnology), or nonspecific rabbit IgG. Oligonucleosomal DNA fragments spanning the Nuc-1 position of the HIV-1 LTR were amplified by PCR using oligonucleotide DNA primers that anneal within nucleotides Ϫ92 to ϩ180 (40) .
Immunostaining and Laser Confocal Microscopy-Co-localization between HIV-1 Tat and WRN proteins was visualized by performing immunofluorescence laser confocal microscopy on post-mortem central nervous system tissue samples (thalamus and basal ganglia) from five donor NeuroAIDS patients (7674, 7996, 11406, 13689, and 14433) with primary HIV-1 encephalopathies and one uninfected control brain (30206). Nonspecific antigens were blocked by incubating slides in 3% (w/v) bovine serum albumin, 0.5% Tween 20 in phosphate-buffered saline for 1 h at room temperature. The slides were then immunostained using rabbit polyclonal anti-HIV-1 Tat (Advanced Bioscience Laboratories) and goat polyclonal anti-WRN (Santa Cruz Biotechnology) primary antibodies diluted 1:2000 in BLOTTO buffer (50 mM Tris-HCl, pH 8.0, 2 mM CaCl 2 , 80 mM NaCl, 0.2% (v/v) IGEPAL CA-630, 0.02% (w/v) sodium azide, 5% (w/v) nonfat dry milk) and incubated for 2 h at room temperature with gentle agitation. Samples were washed 2 times for 10 min with BLOTTO buffer and then incubated with rhodamine red-conjugated anti-rabbit and fluorescein isothiocyanate-conjugated anti-goat secondary antibodies (Jackson Laboratories) for 1 h at room temperature. Laser confocal microscopy and three-dimensional Z-stack composite images were generated using a Nikon TE2000-U inverted microscope/C1 confocal system equipped with dual helium-neon lasers. HIV-1 p24
Gag protein expression was visualized in PHA/ hIL-2-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes by immunostaining with a mouse monoclonal anti-HIV-1 p24 Gag primary antibody (Advanced Bioscience Laboratories) and rhodamine red-conjugated anti-mouse secondary antibody (Jackson Laboratories).
RESULTS
WS Fibroblasts, lacking a functional wrn gene, are impaired for HIV-1 LTR transactivation. To determine whether WRN contributes to HIV-1 LTR transactivation, immortalized human WRN Ϫ/Ϫ WS fibroblasts derived from a Werner syndrome patient (41) and HeLa cells were co-transfected with an HIV-1 LTR-luciferase (firefly) reporter plasmid in the absence or presence of increasing amounts of HIV-1 Tat or a transcriptionally inactive Tat mutant, Tat K28A/K50A (20, 21) . A tk-Renilla luciferase construct was co-transfected to normalize for transfection efficiencies or differences in general transcriptional levels (1) between WRN Ϫ/Ϫ WS fibroblasts and HeLa, which contain endogenous WRN. Significant basal HIV-1 LTRdependent transcription was measured in HeLa cells, whereas WRN Ϫ/Ϫ WS fibroblasts exhibited reduced LTR-dependent transcription (Fig. 1B) . Tat activated the HIV-1 LTR approximately 20-fold in HeLa cells (Fig. 1B) . Surprisingly, human WRN Ϫ/Ϫ WS fibroblasts were severely impaired for Tat-activated HIV-1 LTR-dependent transcription (Fig. 1B) . Results from a representative experiment are shown in Fig. 1B (Fig. 1C) . Increasing CMV-wild type-WRN significantly restored Tat-dependent LTR transactivation (Fig. 1C) . The expression of HIV-1 Tat and WRN (Myc-tagged) proteins was detected by immunofluorescence microscopy (Fig. 1D) . Collectively, these findings indicate that WRN helicase functions are essential for HIV-1 transcription and retroviral replication.
The WRN helicase cooperates with Tat to transactivate the HIV-1 LTR. We next tested the effects of overexpressing wild type WRN upon basal and Tat-activated HIV-1 LTR-dependent transcription by co-transfecting HuT-78 lymphocytes and HeLa cells with HIV-1 LTR-luciferase and RSV-HIV-1 Tat in the absence or presence of CMV-wild type-WRN, CMV-WRN K577M , or C␤S vector control. Tat transactivated the HIV-1 LTR approximately 70-fold in HuT-78 cells ( Fig. 2A) . Overexpression of wild type WRN alone transactivated the HIV-1 LTR approximately 14-fold ( Fig. 2A) . Increasing amounts of CMV-wild type-WRN also resulted in higher Tatdependent LTR transactivation (compare 70-fold for Tat alone to 217-fold for wild type WRN ϩ Tat). By contrast, the helicaseminus WRN K577M mutant inhibited Tat-dependent LTR transactivation in a dose-dependent manner. The C␤S control did not affect Tat-dependent LTR transactivation ( Fig. 2A) . Similar results were obtained using HeLa cells (Fig. 2B) . CMV-wild type-WRN alone transactivated the HIV-1 LTR approximately 6-fold, whereas the WRN K577M mutant repressed basal LTRdependent transcription (Fig. 2B ). Increasing amounts of CMV-wild type-WRN resulted in increased Tat-dependent LTR transactivation (compare 37-fold for Tat alone to 72-fold for wild type WRN ϩ Tat). The helicase-minus WRN K577M mutant markedly inhibited Tat-dependent LTR transactivation (from 37-to approximately 3-fold). The C␤S vector did not affect Tat-dependent LTR transactivation (Fig. 2B ). Neither overexpression of wild type WRN nor WRN K577M altered HIV-1 Tat protein expression (Fig. 2C) . Another related DNA helicase, BLM-associated with Bloom syndrome (44) , which has been shown to interact with WRN (44, 45) did not influence basal or Tat-activated HIV-1 LTR-dependent transcription (data not shown) indicative that effects of WRN upon HIV-1 LTR transactivation are independent of WRN-BLM interactions.
We then investigated whether the effects of WRN upon HIV-1 transcription require the TAR element and Tat/TAR-RNA interactions. Tat binds to a uracil-containing trinucleotide bulge within TAR-RNA and stimulates transcriptional elongation by recruiting cellular factors (e.g. P-TEFb) to the HIV-1 LTR (see diagram, Fig. 2E ) (30 -33, 46, 47) . HeLa cells were co-transfected with a mutant HIV-1 LTR⌬TAR-luciferase reporter plasmid, deleted for the 3-nucleotide bulge within TAR-RNA, and RSV-HIV-1 Tat in the absence or presence of increasing CMV-wild type-WRN or CMV-WRN K577M . Tat only weakly transactivated the HIV-1 LTR⌬TAR-luciferase construct (approximately 2.6-fold, Fig. 2D ). Neither ectopic wild type WRN nor the WRN K577M mutant significantly altered basal or Tat-activated transcription from the HIV-1 LTR⌬TAR (Fig. 2D) . These results indicate that effects of WRN upon HIV-1 LTR-dependent transcription require an intact TAR-RNA element.
WRN is essential for the recruitment of PCAF/P-TEFb transcription complexes to the HIV-1 LTR. To determine whether the effects of WRN upon LTR transactivation reflect direct binding or altered recruitment of transcriptional coactivator/ acetyltransferase proteins to the HIV-1 LTR, we performed LTR-ChIP experiments. Tat interacts with the coactivators, p300/CREB-binding protein and PCAF, on the HIV-1 LTR and these factors acetylate Tat on lysine residues (Lys 28 , Lys 50 , and Lys 51 ), which modulates TAR-RNA binding and interactions with other cofactors, such as P-TEFb (cyclin T1-cdk9) (18 -22, 30, 39) . Balajee et al. (1) have shown that WRN contributes to RNA pol II transcription in a helicase-dependent and helicaseindependent manner. To test whether WRN influences the recruitment of cellular factors to the HIV-1 LTR, HeLa cells and immortalized human WRN Ϫ/Ϫ WS fibroblasts were co-transfected with an episomal HIV-1 LTR-luciferase construct and RSV-HIV-1 Tat. CMV-WRN K577M was co-transfected in certain experiments to inhibit endogenous WRN functions. ChIPs were performed to detect nucleoprotein interactions on the HIV-1 LTR at the Nuc-1 position (Ϫ92 to ϩ180) in the vicinity of Tat/TAR-RNA (Fig. 2E) (40) . These results demonstrate that Tat and cellular cofactors, p300, PCAF, cyclin T1, and WRN, were recruited to the episomal HIV-1 LTR in transfected HeLa cells (Fig. 2F) . Importantly, inhibition of endogenous WRN, through co-expression of the helicase-minus WRN K577M mutant, abrogated recruitment of WRN to Tat-containing LTR complexes and diminished recruitment of PCAF and cyclin T1 (Fig. 2F ). Tat and p300 interactions on the HIV-1 LTR were not affected by WRN K577M . We observed similar impairment in the recruitment of PCAF and cyclin T1 to Tat-containing LTR complexes in transfected immortalized WRN Ϫ/Ϫ WS fibroblasts (Fig. 2F) . Furthermore, we demonstrated that WRN interacts with purified recombinant GST-HIV-1 Tat and the transcriptionally inactive GST-HIV-1 Tat K28A/K50A mutant in biochemical GST pull-down experiments (Fig. 2G) . Our findings suggest that WRN is an essential cofactor for HIV-1 tran- scription, interacts with Tat, and stabilizes the recruitment of PCAF and P-TEFb to Tat/TAR-RNA chromatin remodeling complexes.
The WRN helicase strongly co-localized with HIV-1 Tat in central nervous system tissue sections (thalamus and basal ganglia) from donor HIV-1-infected NeuroAIDS patients with primary viral encephalopathies (Fig. 3A) . Laser confocal microscopy was performed on five patient samples and one uninfected control brain (data not shown) that were immunostained with anti-HIV-1 Tat (red) and anti-WRN (green) primary antibodies and appropriate fluorescent secondary antibodies. A representative three-dimensional Z-stack composite image from a 0 g ) and RSV-HIV-1 Tat (1.0 g) in the absence or presence of CMV-WRN K577M (3.0 g). ChIPs were performed using antibodies against HIV-1 Tat, WRN, p300, PCAF, or cyclin T1 (P-TEFb). A nonspecific rabbit antisera (IgG) control was also included. Immunoprecipitated DNA fragments spanning nucleotides Ϫ92 to ϩ180 in the vicinity of TAR were amplified by PCR using oligonucleotide DNA primers, 5Ј-ACTTTTCCGGGGAGGCGCGATC-3Ј and 5Ј-GCCACTGCTAGAGATTTCCACACTG-3Ј, described in Zhou et al. (40) . G, HeLa cells were transfected with CMV-wild type-WRN (Myc tagged, 3.0 g) and GST pull-down experiments were performed at 4°C using purified recombinant GST-HIV-1 Tat, GST-HIV-1 Tat K28A/K50A (20, 21) , or GST proteins (100 ng). Input levels of GST, GST-HIV-1 Tat, and GST-HIV-1 Tat K28A/K50A and WRN (Myc-tagged) were detected by immunoblotting. Glutathione-Sepharose 4B matrices were pelleted by centrifugation, washed twice with cold phosphate-buffered saline, and bound WRN (Myc) was detected by SDS-PAGE and immunoblotting (lower panel).
single patient (11406) is shown in Fig. 3A . Significant colocalization was observed in merged images, consistent with results in Fig. 2G demonstrating that GST-HIV-1 Tat and WRN interact in vitro.
WRN modulates LTR transactivation and retroviral replication in HIV-1-infected T-lymphocytes. To determine whether ectopic WRN or the helicase-minus WRN K577M mutant influences HIV-1 replication, the virus-producing HIV-1-infected H9 HIV-1IIIB lymphoid cell line (48) was transfected with increasing amounts of CMV-wild type-WRN, CMV-WRN K577M , or a pcDNA3.1-GFP control, and the cultures were stimulated with PHA and recombinant hIL-2 to induce high level HIV-1 replication. After 72 h, cells were harvested and intracellular levels of HIV-1 p24
Gag were determined by immunoblotting with a monoclonal anti-HIV-1 p24
Gag primary antibody. Relative actin levels are provided as a control for equivalent protein loading (Fig. 3B) . Uninfected Jurkat and untransfected PHA/ hIL-2-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes are shown for comparison. Overexpression of wild-type WRN resulted in a dose-dependent increase in intracellular HIV-1 p24
Gag compared with untransfected PHA/hIL-2-stimulated H9 HIV-1IIIB lymphocytes or PHA/hIL-2-stimulated H9 HIV-1IIIB cells transfected with the pcDNA3.1-GFP control (Fig. 3B) . Increasing amounts of the dominant-negative WRN K577M mutant inhibited intracellular HIV-1 p24
Gag production and viral replication in PHA/hIL-2-stimulated transfected H9 HIV-1IIIB cells (Fig. 3B) . Green fluorescent protein (GFP) expression did not alter intracellular HIV-1 p24
Gag levels compared with untransfected PHA/hIL-2-stimulated H9 HIV-1IIIB lymphocytes (Fig. 3B) Gag production was observed by immunoblotting. Relative actin protein levels are provided as a control for equivalent loading. Increased intracellular HIV-1 p24
Gag production was observed with increasing CMV-wild type-WRN, whereas the dominant-negative WRN K577M mutant resulted in reduced HIV-1 replication. Uninfected Jurkat and untransfected PHA/hIL-2-stimulated H9 HIV-1IIIB lymphocytes are shown as controls. C, the clonal HIV-1-infected H9 HIV-1IIIB cell line was co-transfected with pcDNA3.1-GFP (1.0 g), HIV-1 LTR-luc (1.0 g), and increasing amounts (1.0 and 3.0 g) of CMV-WRN K577M or empty C␤S vector control. After 48 h, the transfected cells were stimulated to produce HIV-1 particles by treatment with PHA/hIL-2 as described. The percentages of transfected GFP-expressing T-cells were determined by direct fluorescence microscopy (inset micrographs) and the supernatants were collected and extracellular HIV-1 particles were concentrated by ultracentrifugation at 44,000 ϫ g at 4°C for 24 h. Relative amounts of extracellular HIV-1 p24
Gag protein were determined by immunoblotting. Uninfected HuT-78 lymphocytes were included as a negative control. Relative percentages of extracellular HIV-1 p24
Gag produced by transfected HIV-1-infected H9 HIV-1IIIB lymphocytes are expressed as: 100 Ϫ (⌬HIV-1 p24
Gag /% GFP-positive cells) and are represented by black bars. The cell pellets were lysed by repeated freeze-thawing and relative luciferase activities were measured using equivalent amounts of total cellular proteins. microscopy and counting multiple fields (see inset micrographs, Fig. 3C ). The cells were harvested by centrifugation and supernatants were layered upon a 70% sucrose, Tris-HCl, pH 7.4, cushion and extracellular HIV-1 particles were concentrated by ultracentrifugation. The relative percentages of HIV-1 p24
Gag /GFP-positive cells were determined by immunoblotting and normalization for transfection efficiencies (Fig.  3C) . Relative HIV-1 LTR-luciferase transactivation levels were measured to correlate effects of WRN K577M upon HIV-1 replication with LTR-dependent transactivation (Fig. 3C) . Results in Fig. 3C demonstrate that significant extracellular HIV-1 p24 Gag production and LTR transactivation were observed in transfected, PHA/hIL-2-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes, whereas transfected PHA/hIL-2-stimulated HuT-78 lymphocytes did not exhibit detectable HIV-1 p24
Gag or LTR transactivation. Increasing amounts of CMV-WRN K577M inhibited extracellular p24
Gag production, HIV-1 replication, and LTR-dependent transactivation in a dose-dependent manner (Fig. 3C) . The C␤S vector did not alter HIV-1 replication or LTR transactivation (Fig. 3C) .
The transfection efficiency of lymphoid cells is generally low (approximately 15-40%). Thus, to determine whether the inhibitory effects of WRN K577M upon HIV-1 replication were attributable to partial inhibition in numerous transfected HIV-1-infected cells or near complete inhibition in individual transfected cells, we performed immunofluorescence microscopy to visualize p24
Gag production in transfected, PHA/hIL-2-stimulated H9 HIV-1IIIB lymphocytes expressing the Myc-tagged WRN K577M mutant protein. Slides were immunostained with anti-HIV-1 p24
Gag (red) and anti-Myc tag (green) primary antibodies and appropriate fluorescent secondary antibodies. Surprisingly, p24
Gag was almost undetectable in transfected PHA/ hIL-2-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes expressing WRN K577M (Myc-tagged), whereas high levels of HIV-1 p24
Gag were observed in surrounding untransfected cells (Fig. 4A, top panels) . HIV-1 replication and p24
Gag production are also shown in unstimulated and PHA/hIL-2-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes that were transfected with C␤S vector control (Fig. 4A, lower panels) . Unstimulated HIV-1-infected H9 HIV-1IIIB lymphocytes chronically produce low levels of virus particles as shown in Fig. 4A (lower right panels). As we had observed that overexpression of wild type WRN stimulates HIV-1 replication (Fig. 3B) , we examined whether ectopic WRN (Myc-tagged) influences basal HIV-1 replication in unstimulated transfected H9 HIV-1IIIB lymphocytes as determined by immunofluorescence microscopy. Results in Fig. 4B demonstrate that overexpression of wild type WRN (Myc) induces high level HIV-1 p24
Gag (red) in unstimulated transfected H9 HIV-1IIIB lymphocytes, compared with untransfected surrounding cells. 4Ј,6-Diamidino-2-phenylindole nuclear staining was included to visualize the entire cell population (Fig. 4B) . No significant apoptosis or nuclear condensation was observed in HIV-1-infected H9 HIV-1IIIB lymphocytes expressing the WRN K577M mutant, however, inhibition of endogenous WRN functions by WRN K577M differentially affected (activated/repressed) the transcription of numerous cellular genes in Affymetrix microarray analyses (data not shown).
To better correlate the effects of the dominant-negative WRN K577M mutant protein upon HIV-1 LTR trans-activation and virus replication, we transfected H9 HIV-1IIIB lymphocytes with pcDNA3.1-GFP and increasing amounts of CMV-WRN K577M or the empty C␤S vector control. Green fluorescent protein expression was visualized by direct fluorescence microscopy and GFP positive-transfected cells were isolated by fluorescence-activated cell sorting (Fig. 5A) . We observed that the percentage of GFP positive-transfected cells in total populations was ϳ18 -20% based on FACS analyses. The isolated cells were then subcultured in the presence of hIL-2/PHA to induce high level HIV-1 replication. Expression of the WRN K577M mutant protein significantly inhibited HIV-1 replication as determined by HIV-1 p24
Gag enzyme-linked immunosobent assays (Fig. 5B) . Supernatants from cultured FACSisolated GFP-positive cells were used to infect target HuT-78 lymphocytes, containing the pCV745-HIV-1 LTR-luciferase reporter plasmid, and relative LTR transcriptional activities were measured (Fig. 5C ). Samples were normalized using the tk-Renilla luciferase (Fig. 5C ). These results demonstrate that the inhibitory effects of the WRN K577M mutant upon Gag (red) and anti-Myc tag (green) primary antibodies as described in A. 4Ј,6-Diamidino-2-phenylindole nuclear staining is shown for reference.
HIV-1 replication correlate with inhibition of LTR transactivation in transfected H9 HIV-1IIIB lymphocytes. We next examined recruitment of the WRN helicase to HIV-1 Tat/ LTR complexes in hIL-2/PHA-stimulated HIV-1-infected H9 HIV-1IIIB lymphocytes by ChIP analyses. Results in Fig. 5D demonstrate that HIV-1 LTR-specific oligonucleotide PCR primers (40) amplified precipitated products in anti-Tat and anti-WRN ChIPs. No amplification was observed for the nonspecific IgG control ChIP (Fig. 5D ). Our findings demonstrate that WRN is an essential cofactor for HIV-1 LTR trans-activation and retroviral replication; and WRN may be a plausible target for the development of novel antiretroviral therapies, as inhibition of endogenous WRN functions by the helicase-minus WRN K577M mutant interferes with HIV-1 replication.
DISCUSSION
The HIV-1 Tat protein transactivates the retroviral LTR through concerted interactions with cellular cofactors, including p300/CBP, PCAF/hGCN5, P-TEFb, SET7/ SET9 methyltransferases, SIRT1, Brm SWI/SNF, and SKIP (18 -37, 40) . The PCAF acetyltransferase has been shown to acetylate Tat on Lys 28 , which stimulates the recruitment of P-TEFb to Tat/TAR-RNA complexes associated with RNA pol II COOH-terminal domain phosphorylation and increases the synthesis of full-length HIV-1 mRNAs (20, 30 K577M or an empty C␤S vector control and GFP-expressing cells were sorted and isolated using a BD FACSCaliber instrument. Green fluorescent protein expression in transfected cells was visualized by direct fluorescence microscopy. B, the FACS-isolated GFP-positive cells were subcultured for 6 days in the presence of hIL-2/PHA to induce HIV-1 replication. Effects of the WRN K577M mutant protein upon virus production were determined by performing HIV-1 p24
Gag enzyme-linked immunosobent assays (Advanced Bioscience Laboratories, n ϭ 2). Relative extracellular p24
Gag levels (pg/ml) in HIV-1 infectious supernatants were determined through comparison with a purified p24
Gag protein standard (data not shown). C, supernatants from subcultured FACSisolated WRN K577M /GFP-expressing H9 HIV-1IIIB lymphocytes were used to infect target HuT-78 lymphocytes, containing the pCV745-HIV-1 LTR-luciferase reporter construct, to quantify the effects of HIV-1 infection upon LTR trans-activation. Samples were normalized using tk-Renilla luciferase (data not shown). Error bars representative of standard deviations are shown (n ϭ 2). D, the WRN protein was detected in HIV-1 Tat/LTR complexes in hIL-2/PHA-stimulated H9 HIV-1IIIB lymphocytes by ChIP analyses and PCR amplification using oligonucleotide primers that flank nucleotide positions Ϫ92 to ϩ180 of the HIV-1 LTR (40).
WRN
Ϫ/Ϫ WS fibroblasts (41) , suggest that WRN is required for the stable recruitment of PCAF and P-TEFb to Tat/TAR-RNA transcription complexes on the HIV-1 LTR. These findings are consistent with the HIV-1 LTR transcriptional defect observed in immortalized WRN Ϫ/Ϫ WS fibroblasts as well as with inhibition of HIV-1 p24
Gag production and retroviral replication by the dominant-negative WRN K577M mutant in transfected, HIV-1-infected H9 HIV-1IIIB lymphocytes. Collectively, our results indicate that the WRN helicase is a novel cellular cofactor essential for HIV-1 transcription and replication.
Mutations of wrn cause Werner syndrome associated with premature aging and cellular senescence (50) , which resembles certain symptoms observed during AIDS-related wasting disease, such as loss of skeletal muscle mass, weakness and fatigue, and failure to thrive. Indeed, it is intriguing to speculate that interference with normal WRN functions, as a result of HIV-1 infection and/or Tat binding, could, in part, contribute to an aging phenotype and immune suppression in HIV-1-infected AIDS patients. These studies may help to better understand the molecular events underlying HIV-1 pathogenesis and suggest that WRN might be a plausible new target for anti-retroviral therapy. We have further provided the first evidence that the WRN DNA helicase participates in the recruitment of PCAF/P-TEFb-containing transcription complexes that, mechanistically, may account for the general RNA pol II-dependent transcriptional impairment in immortalized human WRN Ϫ/Ϫ WS fibroblasts reported by Balajee et al. (1) .
